# Genomics Core

> **NIH NIH P30** · LSU PENNINGTON BIOMEDICAL RESEARCH CTR · 2020 · $182,107

## Abstract

Nearly two-thirds of the US population is either clinically overweight or obese, and almost 10%
of the population has adult-onset diabetes. Louisiana is afflicted with even higher incidence, a
fact that provides the public health urgency for obesity and diabetes research conducted under
the auspices of the Center of Biomedical Research Excellence at the Pennington Biomedical
Research Center. Both basic and clinical research in obesity, diabetes, or metabolic syndrome
requires genomics approaches to understand the molecular mechanisms that underlie the
respective pathology. The Genomics Core of the PBRC COBRE seeks to facilitate such
inquiries by providing access to modern genomics technologies that are typically too expensive
for most individual laboratories to procure or to maintain. Based on the scientific requirements of
COBRE and PBRC investigators, the Core has focused on `Functional Genomics', with
measurements of gene expression and epigenomics approaches at center stage. The Specific
Aims of the Core are (1) to make high quality and cost-effective genomics technology available
to investigators, (2) to provide the bioinformatics necessary for the analytical and interpretative
framework for genomics experiments, and (3) to serve as an intellectual and advisory resource
and promote interactions and collaborations among investigators interested in genomics
approaches. Based on a strong record of productivity in the prior two funding periods of the
PBRC COBRE, the impact of the Genomics Core results from the facilitation of research
progress, the removal of critical barriers, specifically in the realm of bioinformatics, and the
creation of scientific synergy through interactions with the Cell Biology and Bioimaging Core, the
Transgenic Core, and PBRC and COBRE investigators. Thus, the Genomics Core is a critical
component to sustain the Center's basic and translational research activities, and obtain new
extramural support.

## Key facts

- **NIH application ID:** 9978085
- **Project number:** 5P30GM118430-05
- **Recipient organization:** LSU PENNINGTON BIOMEDICAL RESEARCH CTR
- **Principal Investigator:** Johannes Michael Salbaum
- **Activity code:** P30 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2020
- **Award amount:** $182,107
- **Award type:** 5
- **Project period:** 2016-08-01 → 2022-07-31

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/9978085

## Citation

> US National Institutes of Health, RePORTER application 9978085, Genomics Core (5P30GM118430-05). Retrieved via AI Analytics 2026-05-22 from https://api.ai-analytics.org/grant/nih/9978085. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*